In total, 22% of primary EBV + DLBCLs (10/46) harbored mutations affecting NOTCH1 or NOTCH2. dNdScv confirmed both genes as significant cancer driver genes (Supplementary Table 4). This evidence concerns the gene NOTCH1 and cancer.